Company intelligence / Profile preview

Primer Ventures

Palo Alto, California, United Statesprimerventures.com ↗

Ownership: Private
Development stage: Other

Overview

Primer Ventures is an early-stage venture capital firm focused on investing in disruptive startups across life science tools and therapeutics. The firm backs entrepreneurs developing innovations in genomics, synthetic biology, molecular diagnostics, cell/gene therapies, regenerative medicine, omics/AI-enabled drug discovery and next-generation analytical equipment. Its portfolio includes companies tackling genetic medicine for autoimmune diseases and targeted therapies for drug resistance.

Modalities: Cell therapyGene therapySmall moleculeBiologicmRNA-based drugs
Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of June 2025.

Beyond the preview

Go deeper on Primer Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primer Ventures.

Explore the full profile